Biotech Firm Dissolves, Terminates 85K SF Cambridge Lease With Alexandria Rubius Therapeutics, a life sciences company that went public at a $2B valuation in 2018, has now dissolved and liquidated assets including its headquarters in Cambridge and its manufacturing facility in Rhode Island.The firm terminated its 85K SF headquarters lease with Alexandria Real Estate Equities at 399 Binney St. in Kendall Square, according to documents filed… Read the full story here. | | |